Funding news
Exobiosphere logo

Exobiosphere Secures $10.

Recently funded · $10.0M SeedTechnology, Information and MediaLUView source

Get the full Exobiosphere company profile

Access contacts, investors, buying signals & more

Open in Dashboard

The final frontier of drug discovery just got a $10.0M boost. Exobiosphere, the world's first space-focused pre-clinical contract research organization, has secured seed funding to advance its mission of leveraging microgravity for biomedical R&D.

The startup is building a standardized, high-throughput testing platform in orbit, allowing pharmaceutical and biotech partners to run automated experiments in space. This approach aims to accelerate drug discovery by creating more physiologically relevant models and observing faster disease development than possible on Earth.

Other Luxembourg companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Seed rounds

Companies that recently closed a Seed round.

#CompanyAmount
1
Hive logo

Hive

United States

$14.0M
2
Arkenstone Defense logo

Arkenstone Defense

United States

$35.0M
3
deelan logo

deelan

$790.0K
4
invitrolize logo

invitrolize

Luxembourg

$2.8M
5
Finergy Tech logo

Finergy Tech

Moldova

$500.0K